Mechanism of Action of Calcium-Channel-Blocking Agents

New England Journal of Medicine

Volumn 307, Issue 26, 1982, Pages 1618-1627

  Epstein, Franklin H ^a   Braunwald, Eugene ^b  

^a Beth Israel Hospital ^*

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; DILTIAZEM; HYDRALAZINE; NIFEDIPINE; PROCAINAMIDE; PROPRANOLOL; QUINIDINE; TETRODOTOXIN; VERAPAMIL;

CARDIOVASCULAR SYSTEM; DRUG EFFICACY; DRUG MECHANISM; HUMAN; NONHUMAN; PERIPHERAL VASCULAR SYSTEM; REVIEW; THERAPY; VASCULAR SMOOTH MUSCLE;

ACTION POTENTIALS; ANGINA PECTORIS; ARRHYTHMIA; BLOOD VESSELS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CORONARY DISEASE; HEART; HEART FAILURE, CONGESTIVE; HUMAN; HYPERTENSION; ION CHANNELS; MODELS, BIOLOGICAL; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL CONTRACTION; MYOCARDIAL DISEASES; MYOCARDIAL INFARCTION; NIFEDIPINE;

EID: 0020429539     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198212233072605     Document Type: Review

References (45)

1. Braunwald E., Sonnenblick E.H., Ross J. Jr. Contraction of the normal heart. In: Braunwald E, ed. Heart disease. Philadelphia: WB Saunders, 1980: 413-52.
2. Adelstein R.S., Eisenberg E. Regulation and kinetics of actin-myosin-ATP interaction. Annu Rev Biochem. 1980; 49:921-956
3. Selaro R.J. The role of calcium in the contraction of the heart. In: Flaim SF, Zelis R, eds. Calcium blockers. Baltimore: Urban & Schwarzenberg, 1982: 21-36.
4. Kramer G.L., Hardman J.G. Cyclic nucleotides and blood vessel contraction. In: Bohr DF, Somlyo A, Sparks HV Jr, eds. Handbook of physiology. Vol. 2. The cardiovascular system. Bethesda, Md.: American Physiological Society, 1980: 179-99.
5. Vallet B., Molla A., Demaille J.G. Cyclic adenosine 3′,5′-monophosphate-dependent regulation of purified bovine aortic calcium/calmodulin-dependent myosin light chain kinase. Biochim Biophys Acta. 1980; 674:256-264
6. Carmeliet E. The slow inward current: nonvoltage-clamp studies. In: Zipes DP, Bailey JC, Elharrar V, eds. The slow inward current and cardiac arrhythmias. Boston: Martinus Nijhoff, 1980: 97-110.
7. Reuter H., Scholz H. A study of the ion selectivity and the kinetic properties of the calcium dependent slow inward current in mammalian cardiac muscle. J Physiol (Lond). 1977; 264:17-47.
8. Barry W.H., Biedert S., Miura D.S., Smith T.W. Changes in cellular Na+, K+, and Ca2+ contents, monovalent cation transport rate, and contractile state during washout of cardiac glycosides from cultured chick heart cells. Circ Res. 1981; 49:141-149
9. Caroni P., Carafoli E. An ATP-dependent Ca+-pumping system in dog heart sarcolemma. Nature. 1980; 283:765-767
10. Katz A.M. Role of the contractile proteins and sarcoplasmic reticulum in the response of the heart to catecholamines: an historical review. Adv Cyclic Nucleotide Res. 1979; 11:303-343
11. Triggle D.J. Biochemical pharmacology of calcium blockers. In: Flaim SF, Zelis R, eds. Calcium channel blockers: mechanisms of action and clinical applications. Baltimore: Urban & Schwarzenberg, 1982: 121-34.
12. Triggle D.J., Swamy V.C. Pharmacology of agents that affect calcium: agonists and antagonists. Chest. 1980; 78: Suppl: 174-9.
13. van Breemen C., Aaronson P., Loutzenhiser R. Sodium-calcium interactions in mammalian smooth muscle. Pharmacol Rev. 1978; 30:167-208.
14. Fleckenstein A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol. 1977; 17:149-166
15. Vatner S.F., Hintze D.H. Effects of a calcium-channel antagonist on large and small coronary arteries in conscious dogs. Circulation. 1982; 66:579-588
16. Ginsburg R., Bristow M.R., Harrison D.C., Stinson E.B. Studies with isolated human coronary arteries: some general observations, potential mediators of spasm, role of calcium antagonists. Chest. 1980; 78: Suppl: 180-6.
17. Braunwald E. Calcium-channel blockers: pharmacologic considerations. Am Heart J. 1982; 104:665-671
18. Amman E., Muller J., Goldberg S., et al. Nifedipine therapy for Coronary Artery spasm: experience in 127 patients. N Engl J Med. 1980; 302:1269-1273
19. Braunwald E. Coronary artery spasm as a cause of myocardial ischemia. J Lab Clin Med. 1981; 97:299-312.
20. Stone P.H., Muller J.E. Nifedipine therapy for recurrent ischemic pain following myocardial infarction. Clin Cardiol. 1982; 5:223-230
21. Stone P.H., Turi Z.G., Muller J.E. Efficacy of nifedipine therapy for refractory angina pectoris. Am Heart J. 1982; 104:672-681
22. Gunther S., Green L., Muller J.E., Mudge G.H. Jr., Grossman W. Prevention by nifedipine of abnormal coronary vasoconstriction in patients with coronary artery disease. Circulation. 1981; 63:849-855
23. Engle H.-J., Lichtlen P.R. Beneficial enhancement of coronary blood flow by nifedipine: comparison with nitroglycerin and beta blocking agents. Am J Med. 1981; 71:658-666
24. Kern M., Ganz P., Horowitz J., Mudge G.H. Jr., Grossman W. Potentiation of coronary vasoconstriction by β-adrenergic blockade. Circulation. 1981; 64: Suppl 4:IV-82.
25. Lorell B.H., Turi Z., Grossman W. Modification of left ventricular response to pacing tachycardia by nifedipine in patients with coronary artery disease. Am J Med. 1981; 71:667-675
26. Mueller H.S., Chahine R.A. Interim report of multicenter double-blind, place-bo-controlled studies of nifedipine in chronic stable angina. Am J Med. 1981; 71:645-655
27. Dargie H.J., Lynch P.G., Krikler D.M., Harris L., Krikler S. Nifedipine and propranolol: a beneficial drug interaction. Am J Med. 1981; 71:676-682
28. Strauss W.E., Mclntyre K.M., Parisi A.F., Shapiro W. Safety and efficacy of diltiazem hydrochloride for the treatment of stable angina pectoris: report of a cooperative clinical trial. Am J Cardiol. 1982; 49:560-566
29. DeBoer L.W.V., Strauss H.W., Kloner R.A., et al. Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size after experimental coronary artery occlusion. Proc Natl Acad Sci USA. 1980; 77:6119-6123
30. Bussman W.D. Use of vasodilators in acute myocardial infarction. Proceedings of the International Symposium on Limiting Infarct Size. Tagung Der Deutschen Gesellschaft für Inners Medizin. 1982:129. abstract.
31. Henry P.D., Shuchleib R., Clark R.E., Perez J.E. Effect of nifedipine on myocardial ischemia: analysis of collateral flow, pulsatile heat and regional muscle shortening. Am J Cardiol. 1979; 44:817-824
32. Henry P.D., Shuchleib R., Davis J., Weiss E.S., Sobel B.E. Myocardial contracture and accumulation of mitochondrial calcium in ischemic rabbit heart. Am J Physiol. 1977; 233:H677-84.
33. Kloner R.A., DeBoer L.W.V., Carlson N., Braunwald E. The effect of verapamil on myocardial ultrastructure during and following release of coronary artery occlusion. Exp Mol Pathol. 1982; 36:277-286
34. Clark R.E., Christlieb I.Y., Ferguson T.B., et al. Laboratory and initial clinical studies of nifedipine, a calcium antagonist for improved myocardial preservation. Ann Surg. 1981; 193:719-732
35. Antman E.M., Stone P.H., Muller J.E., Braunwald E. Calcium channel blocking agents in the treatment of cardiovascular disorders. I. Basic and clinical electrophysiologic effects. Ann Intern Med. 1980; 93:875-885
36. Singh B.N., Collett J.T., Chew C.Y. New perspectives in the pharmacologic therapy of cardiac arrhythmias. Prog Cardiovasc Dis. 1980; 22:243-301.
37. Rowland E., Evans T., Krikler D. Effect of nifedipine on atrioventricular conduction as compared with verapamil: intracardiac electrophysiological study. Br Heart J. 1979; 42:124-127
38. Stone P.H., Antman E.M., Muller J.E., Brauwald E. Calcium channel blocking agents in the treatment of cardiovascular disorders. II. Hemodynamic effects and clinical applications. Ann Intern Med. 1980; 93:886-904.
39. Kambara H., Fujimoto K., Wakabayashi A., Kawai C. Primary pulmonary hypertension: beneficial therapy with diltiazem. Am Heart J. 1981; 101:230-231
40. Matsumoto S., Ito T., Sada T., et al. Hemodynamic effects of nifedipine in congestive heart failure. Am J Cardiol. 1980; 46:476-480
41. Klugmann S., Salvi A., Camerini F. Haemodynamic effects of nifedipine in heart failure. Br Heart J. 1980; 43:440-446
42. Lorell B.H., Paulus W.J., Grossman W., Wynne J., Cohn P.F. Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy. Circulation. 1982; 65:499-507.
43. Rosing D.R., Condit J.R., Maron B.J., et al. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. III. Effects of long-term administration. Am J Cardiol. 1981; 48:545-553
44. Rouleau J.-L., Chuck L.H.S., Hollosi G., et al. Verapamil preserves myocardial contractility in the hereditary cardiomyopathy of the Syrian hamster. Circ Res. 1982; 50:405-412
45. Flaim S.F., Zelis R. Calcium channel blockers: mechanisms of action and clinical applications. Baltimore: Urban & Schwarzenberg, 1982.